Nate Barin

Nate Barin is a seasoned professional in regulatory operations and affairs, currently serving as Senior Director of Regulatory Operations at Edgewise Therapeutics since October 2025. Prior to this role, Nate held the position of Senior Director of Regulatory Affairs Operations at Fate Therapeutics Inc. from June 2022 to October 2025, and served in various regulatory roles at MEI Pharma, Intercept Pharmaceuticals, Halozyme Therapeutics, Amylin Pharmaceuticals, Isis Pharmaceuticals, and Pfizer, accumulating extensive experience across multiple aspects of regulatory operations. Nate's educational background includes a Bachelor of Arts degree in Psychology from The Ohio State University.